Dinesh M. Kumar - 23 Jan 2024 Form 4 Insider Report for Apollo Medical Holdings, Inc. (ASTH)

Role
Officer
Signature
/s/ Dinesh M. Kumar
Issuer symbol
ASTH
Transactions as of
23 Jan 2024
Net transactions value
$0
Form type
4
Filing time
24 Jan 2024, 16:31:15 UTC
Previous filing
31 Mar 2023
Next filing
05 Aug 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMEH Common Stock Award $0 +85,130 $0.000000 85,130 23 Jan 2024 Direct F1
transaction AMEH Common Stock Award $0 +16,316 +19% $0.000000 101,446 23 Jan 2024 Direct F2
transaction AMEH Common Stock Award $0 +16,316 +16% $0.000000 117,762 23 Jan 2024 Direct F3
transaction AMEH Common Stock Award $0 +13,053 +11% $0.000000 130,815 23 Jan 2024 Direct F4
transaction AMEH Common Stock Award $0 +13,053 +10% $0.000000 143,868 23 Jan 2024 Direct F5
transaction AMEH Common Stock Award $0 +6,527 +4.5% $0.000000 150,395 23 Jan 2024 Direct F6, F7, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, the shares will vest in three equal annual installments beginning on January 23, 2025, subject to accelerated vesting in certain cases.
F2 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.
F3 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.
F4 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.
F5 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, the shares will vest in four equal semi-annual installments beginning on July 1, 2024.
F6 Restricted shares of the Issuer's common stock granted pursuant to the Issuer's Employment Inducement Award Plan. Provided the Reporting Person is still employed with the Issuer on the date of vesting, and subject to the achievement of applicable pre-established performance goals, half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024 and half of the shares will vest in four equal semi-annual installments beginning on July 1, 2024.
F7 Includes 150,395 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 85,130 shares, which will vest in three equal annual installments beginning on January 23, 2025; (ii) 16,316 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals; (iii) 16,316 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals;
F8 (cont.) (iv) 13,053 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals; (v) 13,053 shares, which will vest in four equal semi-annual installments beginning July 1, 2024, subject to the achievement of certain performance goals; and (vi) 6,527 shares, half of which will vest in four equal semi-annual installments beginning July 1, 2024 and half of which will vest in four equal semi-annual installments beginning July 1, 2024, in each case subject to the achievement of certain performance goals.

Remarks:

Chief Medical Officer of ApolloCare Enablement of Nevada, Inc., a wholly owned subsidiary of Apollo Medical Holdings, Inc.